SITC Archive Library

The Society for Immunotherapy of Cancer (SITC) hosted the “Immuno-Resistance and Sequencing Symposium” during the 36^th Annual Meeting & Pre-Conference Programs on November 11, 2021. Available here are the presentation slides and video from “Session I: Novel Primary vs. Adaptive Resistance Mechanisms,” as permitted by presenters.

Program Summary

While immunotherapy treatments, particularly anti-PD-1 therapies, have improved outcomes for some patients, the issue of post-treatment relapse remains a large problem. The proper choice of treatment after relapse on checkpoint inhibition is, therefore, a critical issue to solve. This symposium explored the preclinical and clinical data on sequencing of immunotherapies, in order to improve patient outcomes and ensure the field of immunotherapy remains at the forefront of oncology care.

Program Organizers

• Elizabeth M. Jaffee, MD – Sidney Kimmel Cancer Center, Johns Hopkins University
• Samir N. Khleif, MD –  Georgetown University Medical Center
• Ira Mellman, PhD –  Genentech, Inc.
• Padmanee Sharma, MD, PhD – The University of Texas MD Anderson Cancer Center

To view the entire program schedule (including presenter permission to post) please click here.